ResearcherCedars-Sinai Medical CenterActive in the last 2 years
Brent K. Larson
Matched on ORCID iD 0000-0002-8116-1089; OpenAlex author ID A5056335583. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 56
2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 5 papers · 2025: 1 paper · 2026: 1 paper
Papers 12
- Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreat… Co-author DOI 10.1200/jco-25-02199↗
- Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care. Co-author DOI 10.1016/j.hpb.2025.07.012↗
- Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jama.2024.16332↗
- Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/ajcp/aqae038↗
- Keratin 17 modulates the immune topography of pancreatic cancer. Co-author DOI 10.1186/s12967-024-05252-1↗
- A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. First author DOI 10.18632/oncotarget.28659↗
- The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analy… Co-author DOI 10.3390/cancers16050971↗
- Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018. Co-author DOI 10.1053/j.gastro.2023.01.022↗
- Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. Co-author DOI 10.1016/j.pan.2021.09.015↗
- Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.humpath.2019.05.004↗
- Pancreatic cancer 'mismatch' in Lynch syndrome. First author DOI 10.1136/bmjgast-2019-000274↗
- Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration. Co-author DOI 10.1016/j.ajpath.2016.09.012↗
Closest collaborators
The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew Eugene Hendifar · 10 shared papers, 2019–2026 · strength 1.67
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659↗
- Paper Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Select… DOI 10.1200/jco-25-02199↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Arsen Osipov · 7 shared papers, 2022–2026 · strength 1.36
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659↗
- Paper Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1001/jama.2024.16332↗
- Paper Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Select… DOI 10.1200/jco-25-02199↗
- Simon K. Lo · 5 shared papers, 2022–2025 · strength 0.89
- Paper Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1001/jama.2024.16332↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Srinivas Gaddam · 4 shared papers, 2023–2025 · strength 0.75
- Paper Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma. DOI 10.1001/jama.2024.16332↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Nicholas N. Nissen · 4 shared papers, 2022–2025 · strength 0.65
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Jun Gong · 4 shared papers, 2019–2025 · strength 0.61
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Stephen Jacob Pandol · 4 shared papers, 2017–2024 · strength 0.52
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 200… DOI 10.1053/j.gastro.2023.01.022↗
- Cristina Rosa Ferrone · 2 shared papers, 2024–2025 · strength 0.43
- Michelle Guan · 3 shared papers, 2019–2022 · strength 0.37
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarci… DOI 10.1016/j.humpath.2019.05.004↗
- Paper Pancreatic cancer 'mismatch' in Lynch syndrome. DOI 10.1136/bmjgast-2019-000274↗
- Natalie Moshayedi · 2 shared papers, 2022–2026 · strength 0.33
- Emanuel F. Petricoin · 2 shared papers, 2024 · strength 0.33
- Lucia Roa‐Peña · 2 shared papers, 2024 · strength 0.33
- Lyanne Delgado Coka · 2 shared papers, 2024 · strength 0.33
- Luisa F. Escobar‐Hoyos · 2 shared papers, 2024 · strength 0.33
- Kenneth Reed Shroyer · 2 shared papers, 2024 · strength 0.33
- Wei Jiang · 2 shared papers, 2024 · strength 0.33
- Lynn McCormick Matrisian · 2 shared papers, 2024 · strength 0.33
- Yazan Abboud · 2 shared papers, 2023–2024 · strength 0.32
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Paper Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 200… DOI 10.1053/j.gastro.2023.01.022↗
- Debiao Li · 2 shared papers, 2023–2024 · strength 0.32
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971↗
- Paper Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 200… DOI 10.1053/j.gastro.2023.01.022↗
- Murtaza Ahmed · 1 shared paper, 2024 · strength 0.28
- Nilofer Saba Azad · 1 shared paper, 2024 · strength 0.28
- Gerardo Perrotta · 1 shared paper, 2024 · strength 0.24
- Ghada Mohamed · 1 shared paper, 2024 · strength 0.24
- Richard Tuli · 2 shared papers, 2019 · strength 0.23
- Davendra P. S. Sohal · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.